Table 2.
Neonatal morbidities of study population.
| non-PIH (n = 1,624) | PIH (n = 203) | p value | |
|---|---|---|---|
| RDS | 1522 (93.7) | 191 (94.1) | 1.000 |
| Treated PDA | 828 (51) | 107 (52.7) | 0.656 |
| IVH ≥ grade 3 | 172 (10.6) | 11 (5.4) | 0.018 |
| PVL | 182 (11.2) | 16 (7.9) | 0.187 |
| NEC | 100 (6.2) | 19 (9.4) | 0.095 |
| Treated ROP | 254 (22) | 34 (25.2) | 0.385 |
| BPD | 673 (41.4) | 91 (44.8) | 0.366 |
| Postnatal steroid | 608 (37.4) | 70 (34.5) | 0.441 |
| Sepsis | 427 (26.3) | 58 (28.6) | 0.500 |
| Ventilator duration (days) | 24.1 ± 31.9 | 25.6 ± 36 | 0.547 |
| TPN duration (days) | 33.9 ± 28.6 | 38.5 ± 28 | 0.031 |
| Hospital days | 87 ± 38.3 | 90.8 ± 42.4 | 0.185 |
Values are expressed as N (%) or Mean ± SD; PIH, pregnancy induced hypertension; RDS, respiratory distress syndrome; PDA, patent ductus arteriosus; IVH, intraventricular hemorrhage; PVL, periventricular leukomalacia; NEC, necrotizing enterocolitis; ROP, retinopathy of prematurity; BPD, bronchopulmonary dysplasia; TPN, total parental nutrition.